Isthmin2: A Potential Drug Target for Muscle-Related Diseases

Target Name: ISM2

NCBI ID: G145501

ISM2

Isthmin2: A Potential Drug Target for Muscle-Related Diseases

The Isthmin2 protein is a key regulator of muscle growth and maintenance, and is a potential drug target for muscle-related diseases. Isthmin2 is a protein that plays a crucial role in the regulation of myogenesis, which is the process by which muscle cells differentiate into functional muscles. Isthmin2 is a 21-kDa protein that is expressed in a variety of tissues, including muscle, heart, and bone. It is composed of two distinct domains: an N-terminal transmembrane domain and a C-terminal cytoplasmic domain. The N-terminal domain is responsible for the protein's cytoplasmic localization, while the C-terminal domain is involved in the regulation of the myogenic transduction pathway.

The Isthmin2 gene is located on chromosome 18, and has been implicated in a number of muscle-related diseases, including muscle dystrophy, muscle weakness, and muscle wasting. In muscle dystrophy, muscle cells are replaced with scar tissue, leading to progressive muscle weakness and wasting. In muscle weakness, muscle cells are not replaced, but rather lost, leading to muscle weakness and decreased physical activity. In muscle wasting, muscle cells are replaced with connective tissue, leading to muscle weakness and decreased physical activity.

Despite the significant impact of Isthmin2 on muscle growth and maintenance, much is still not known about its precise function. The cytoplasmic domain of Isthmin2 has been shown to play a crucial role in the regulation of the myogenic transduction pathway. Isthmin2 has been shown to interact with the transcription factor, MyoD8, and to regulate the translation of genes in the myogenic transduction pathway.

One of the key functions of Isthmin2 is its role in the regulation of muscle cell proliferation. Isthmin2 has been shown to play a role in the regulation of myoblast cell proliferation mediated by the signaling pathway. This signaling pathway involves many important molecular mechanisms, including cell cycle, mitosis and apoptosis. Through these mechanisms, Isthmin2 can control the proliferation and differentiation of muscle cells.

Isthmin2 is also involved in regulating muscle cell apoptosis. Apoptosis is an important way of cell death that can help maintain the homeostasis of tissues and organs. The occurrence of apoptosis is also regulated by many signaling molecules, including Isthmin2. Studies have shown that Isthmin2 can regulate the apoptosis of muscle cells, thereby playing a key role in the differentiation and regeneration of muscle cells.

Isthmin2 is also involved in regulating muscle cell morphology. The morphology of muscle cells is critical to muscle function. Isthmin2 participates in regulating the morphology of muscle cells by regulating the morphology and quantity of sarcoplasmic reticulum. The sarcoplasmic reticulum is an important organelle responsible for the synthesis and modification of proteins and plays an important role in muscle cells.

Isthmin2 is also involved in regulating signal transduction in muscle cells. Signal transduction is an important information transmission process in muscle cells. Isthmin2 regulates signal transduction in muscle cells by binding to receptor proteins, thereby participating in the morphology and function of muscle cells.

Summarize

Isthmin2 is an important protein involved in regulating muscle growth and maintenance. Research shows that Isthmin2 plays an important role in the occurrence of muscle diseases. As a potential drug target, Isthmin2 can provide new treatment methods and research directions.

Protein Name: Isthmin 2

The "ISM2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ISM2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets